专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明申请

US20060265231A1 Aggregation-based management of a distributed business process application 失效
标题翻译：分布式业务流程应用程序的基于聚合的管理
公开(公告)号：US20060265231A1
公开(公告)日：2006-11-23
申请号：US11132056
申请日：2005-05-18
申请人： Eddie Fusaro , Vladimir Pogrebinsky , Arunachallam Sivakumar , Satish Thatte , Neilton Saari , Wei Xiao , Girish Mittur Venkataramanappa
发明人： Eddie Fusaro , Vladimir Pogrebinsky , Arunachallam Sivakumar , Satish Thatte , Neilton Saari , Wei Xiao , Girish Mittur Venkataramanappa
IPC分类号： G06Q99/00
CPC分类号： G06Q10/06 , G06Q10/10
摘要： A system for managing an application set is disclosed. The system includes a wrapper that designates a component as belonging to the application set and an interface that provides access to the component. The system also includes a control module that uses the interface to manage the component. Methods of using the system are also provided.
摘要翻译：公开了一种用于管理应用程序集的系统。系统包括将组件指定为属于应用程序集的包装器和提供对组件的访问的接口。该系统还包括一个控制模块，该控制模块使用接口来管理组件。还提供了使用该系统的方法。

42. 发明申请

US20060207011A1 Safety bath and shower mat 有权
公开(公告)号：US20060207011A1
公开(公告)日：2006-09-21
申请号：US11082946
申请日：2005-03-18
申请人： Daniel Meyers , Cristian Boar , Wei Xiao
发明人： Daniel Meyers , Cristian Boar , Wei Xiao
IPC分类号： A47K3/02
CPC分类号： A47K3/002
摘要： A safety mat for use in bathtubs or shower stalls provides comfortable and safe conditions for users during a bath or shower. The safety mat can be optionally used with a seating aid placed directly on a floor of a bathtub or shower stall, and restrains substantial movement of the seating aid in order to prevent a user sitting on the seating aid from falling therefrom.

43. 发明申请

US20060165721A1 Cinnamomi and poria composition, method to prepare same and uses thereof 有权
公开(公告)号：US20060165721A1
公开(公告)日：2006-07-27
申请号：US11389441
申请日：2006-03-24
申请人： Wei Xiao
发明人： Wei Xiao
IPC分类号： A61K36/54 , A61K36/09 , G01N33/00
CPC分类号： A61K36/54 , A61K36/076 , A61K36/23 , A61K36/65 , A61K36/736 , G01N30/02 , A61K2300/00
摘要： This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

44. 发明授权

US06919094B1 Composition of medicine for treating headache disease and process of preparation and uses thereof 有权
标题翻译：用于治疗头痛疾病的药物组合物及其制备方法及其用途
公开(公告)号：US06919094B1
公开(公告)日：2005-07-19
申请号：US10380273
申请日：2000-09-12
申请人： Wei Xiao
发明人： Wei Xiao
IPC分类号： A61K20060101 , A61K36/00 , A61K36/236 , A61K36/8988 , A61P7/02 , A61P9/00 , A61P9/12 , A61P25/06 , A61K35/78
CPC分类号： A61K36/236 , A61K36/8988 , A61K2300/00
摘要： This invention relates to a medicine combination used to treat headache, which is made up of Chuanxiong and Tianma in a certain scientific weight proportion. The medicine combination can be made into any commonly used dosage form. The invention also provides other applications of this medicine combination in the production of an anti-oxidative drug, an antihypertensive drug, a platelet antiaggregation drug, an antithrombosis drug and an anticoagulant.
摘要翻译：本发明涉及一种用于治疗头痛的药物组合，其以科学的重量比例由川雄和天马组成。药物组合可以制成任何常用的剂型。本发明还提供了该药组合在生产抗氧化药物，抗高血压药物，血小板抗聚集药物，抗血栓形成药物和抗凝血剂中的其它应用。

45. 发明申请

US20050106276A1 Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof 审中-公开
标题翻译：中药材制成的药物组合物及其制备方法
公开(公告)号：US20050106276A1
公开(公告)日：2005-05-19
申请号：US10497032
申请日：2001-11-29
申请人： Wei Xiao
发明人： Wei Xiao
IPC分类号： A61K9/48 , A61K36/00 , A61K36/07 , A61K36/40 , A61K36/65 , A61K36/804 , A61K36/884 , A61K36/8945 , A61P1/14 , A61P3/06 , A61P3/10 , A61K35/78
CPC分类号： A61K9/4858 , A61K36/07 , A61K36/40 , A61K36/65 , A61K36/804 , A61K36/884 , A61K36/8945 , A61K2300/00
摘要： This invention has published a composition of medicine and its preparation, which can treat diabetes, hyperlipemia, fatigue and hypoxia. The preparation is as following: 300-1000 part-by-weight of prepared rehmannia root, 150-600 part-by-weight of prepa red dogwood fruit, 100-450 part-by-weight of tree peony bark, 150-600 part-by-weight of chinese yam, 100-450 part-by-weight of indian bread, 100-450 part-by-weight of alisma rhizome, right amount of refined edible vegetable oil are the materials; the tree peony bark is distilled; the residue of the tree peony bark after distillation, the prepared rehmannia root, the chinese yam and the indian bread are decocted to get the mixed liquor; the paeonol mother liquor is added into the mixed liquor to get extracturm I by centrifugation and concentration; the prepared dogwood fruit and the alisma rhizome are extracted in the refluxing alcohol; the extract is concentrated to get extracturm II; the extracturm I and II are mixed and concentrated to the thick paste; the thick paste is dehydrated in the vacuum, smashed and sifting; The refined paeonol is smashed and added into the extracturm powder; the mixed powder is added with right amount of supplementary materials and milled by the colloid mill, sifting screening; the fine powder is made into soft capsule. The invented capsule has the features of bringing into play in a shorter time, better curative effect and lower dose for oral administration, easier to administrate and stable product quality.
摘要翻译：本发明公开了一种可以治疗糖尿病，高脂血症，疲劳和缺氧的药物及其制剂。制备方法如下：制备的地黄300-1000重量份，红花果实150-600重量份，树牡丹皮100-450重量份，树皮牡丹皮150-600重量份中国山药重量，100-450份印度面包，100-450份重量的异黄酮根茎，适量的精制食用植物油均为原料; 树牡丹皮蒸馏; 蒸馏后的牡丹皮树脂残留物，准备的地黄根，山药和印度面包均被煎煮得到混合液; 加入混合液中的芍药醇母液通过离心浓缩得到提取物I; 在回流酒中提取准备好的山茱萸果实和alisma根茎; 提取物浓缩得到extracturm II; 将提取物I和II混合并浓缩成稠糊状物; 厚糊在真空中脱水，粉碎和筛分; 将精制的芍药醇粉碎并加入到提取物粉末中; 混合粉末加入适量的辅料，经胶体磨研磨，筛分筛选; 细粉末制成软胶囊。本发明胶囊具有在较短时间内发挥作用，较好的治疗效果和较低的口服剂量，更易于管理和稳定的产品质量。

46. 发明授权

US5998602A RNase L activators and antisense oligonucleotides effective to treat RSV infections 失效
标题翻译： RNase L激活剂和有效治疗RSV感染的反义寡核苷酸
公开(公告)号：US5998602A
公开(公告)日：1999-12-07
申请号：US801898
申请日：1997-02-14
申请人： Paul F. Torrence , Robert Hugh Silverman , Nick Mario Cirino , Guiying Li , Wei Xiao
发明人： Paul F. Torrence , Robert Hugh Silverman , Nick Mario Cirino , Guiying Li , Wei Xiao
IPC分类号： C12N15/09 , A61K31/00 , A61K31/70 , A61K31/7088 , A61K38/00 , A61K48/00 , A61P31/00 , A61P31/14 , C07H21/00 , C12N15/00 , C12N15/113 , C12Q1/68 , C12R1/92
CPC分类号： C12N15/1131 , A61K47/48092 , C07H21/00 , A61K38/00 , C12N2310/31 , C12N2310/321
摘要： The invention concerns a compounds and methods for treating infection with Respiratory Syncytial Virus. The compounds comprise an antisense portion, which is complementary to a normally single stranded portion of the RSV antigenomic strand (the mRNA strand), a linker and a oligonucleotide activator of RNase L, a ubiquitous non-specific RNase. The method comprised forming a complex of an activated RNase L and the antisense molecule. The application teaches methods of determining which portions of the RSV antigenomic strand are normally single-stranded. The application teaches that an antisense oligonucleotide having the sequence of residues 8281-8299 of the RSV genome is particularly useful to practice the invention and provides in vitro results superior to those obtainable with the conventional drug of choice, ribavirin.
摘要翻译：本发明涉及用于治疗呼吸道合胞病毒感染的化合物和方法。所述化合物包含与RSV反基因组链（mRNA链）的正常单链部分，RNase L的寡聚核苷酸激活剂，普遍存在的非特异性核糖核酸酶互补的反义部分。该方法包括形成活化的RNA酶L和反义分子的复合物。该申请教导了确定RSV基因组的哪些部分通常是单链的方法。该申请教导了具有RSV基因组残基8281-8299序列的反义寡核苷酸对于实施本发明特别有用，并提供优于常规选择药物利巴韦林可获得的结果。

47. 发明申请

US20140221406A1 QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE 有权
标题翻译：喹唑啉-7-醚化合物及其使用方法
公开(公告)号：US20140221406A1
公开(公告)日：2014-08-07
申请号：US14118200
申请日：2012-05-17
申请人： Wang Shen , Wei Xiao , Jack Maung , Aimin Zhang , Xiaoling Zheng , Zhenzhong Wang , Qingming Guo , Yingguang Li
发明人： Wang Shen , Wei Xiao , Jack Maung , Aimin Zhang , Xiaoling Zheng , Zhenzhong Wang , Qingming Guo , Yingguang Li
IPC分类号： C07D405/12 , C07D493/04
CPC分类号： C07D405/12 , C07D493/04
摘要： The invention provides quinazoline-7-ether derivatives, particularly 4-anilinyl-6-butenamido-quinazoline-7-ether derivatives that are inhibitors of the receptor protein tyrosine kinases (RTK). The compounds are useful in the treatment of diseases and disorders where RTK activity is implicated such as a hyperproliferative diseases (e.g., cancer). Also provided are methods of preparation of the quinazoline derivatives and methods of use as therapeutic agents alone or in a drug combination.
摘要翻译：本发明提供了喹唑啉-7-醚衍生物，特别是作为受体蛋白酪氨酸激酶（RTK）抑制剂的4-苯乙烯基-6-丁烯酰氨基 - 喹唑啉-7-醚衍生物。所述化合物可用于治疗涉及RTK活性的疾病和病症，例如过度增殖性疾病（例如癌症）。还提供了制备喹唑啉衍生物的方法和单独使用或作为药物组合用作治疗剂的方法。

48. 发明申请

US20120179025A1 CT AND MRI SYNCHRONOUS DETECTION POSITIONING NEEDLE 失效
标题翻译： CT和MRI同步检测定位针
公开(公告)号：US20120179025A1
公开(公告)日：2012-07-12
申请号：US13377044
申请日：2011-04-25
申请人： Dedong Ma , Wei Xiao , Qingshi Zeng , Ying Xing , Hongxiu Lu
发明人： Dedong Ma , Wei Xiao , Qingshi Zeng , Ying Xing , Hongxiu Lu
IPC分类号： A61B5/055 , A61M5/00 , A61B6/03
CPC分类号： A61B5/0035 , A61B5/055 , A61B6/032 , A61B6/12 , A61B17/3403 , A61B90/10 , A61B90/37 , A61B2017/3405 , A61B2090/3954 , A61B2090/3966 , A61B2090/3995 , A61M5/427 , A61M5/46
摘要： Disclosed is a CT and MRI synchronous detection positioning needle. The needle comprises a silicone tube which is internally provided with a guide needle; the two sides of the guide needle are provided with hollow cavities; each hollow cavity is internally provided with membranes dividing the hollow cavity into a plurality of small chambers which are filled with liquid, wherein a CT contrast agent is filled in a plurality of small chambers at one side of the guide needle, and an MRI contrast agent is filled in a plurality of small chambers at the other side of the guide needle. In the invention, specially designed silicone positioning needles are implanted in vivo, and synchronous comparison of different image data and pathological data is implemented by means of multi-plane reconstruction technology, so the CT and MRI synchronous detection positioning needle can be widely applied to experimental study on tumors.
摘要翻译：公开了一种CT和MRI同步检测定位针。该针包括内部设置有引导针的硅胶管; 引导针的两侧设有中空腔; 每个中空腔内部设置有将中空腔分成多个填充有液体的小室的膜，其中CT造影剂填充在引导针一侧的多个小室中，并且MRI造影剂被填充在引导针的另一侧的多个小室中。在本发明中，特别设计的硅胶定位针植入体内，通过多平面重建技术实现不同图像数据和病理数据的同步比较，CT和MRI同步检测定位针可广泛应用于实验研究肿瘤。

49. 发明申请

US20120122459A1 METHOD, APPARATUS, AND SYSTEM FOR VOICE CALL FALLBACK TO CIRCUIT SWITCHED DOMAIN 有权
标题翻译：用于语音呼叫倒退到电路切换域的方法，装置和系统
公开(公告)号：US20120122459A1
公开(公告)日：2012-05-17
申请号：US13356201
申请日：2012-01-23
申请人： Xiaobo Wu , Hai Liu , Wei Xiao
发明人： Xiaobo Wu , Hai Liu , Wei Xiao
IPC分类号： H04W36/36 , H04L12/66 , H04W68/00
CPC分类号： H04W36/0022 , H04W8/26 , H04W36/14 , H04W68/00 , H04W72/042 , H04W76/10
摘要： A method for voice call fallback to a circuit switched (CS) domain disclosed in the present invention includes: receiving a Service Request message from a calling user equipment (UE), where the Service Request message includes called number information of a voice call in a CS domain, instructing an evolved NodeB (eNB) to initiate circuit switched fallback (CSFB) handover; receiving a Handover Request message from the eNB, where the Handover Request message includes information required for CS handover, selecting a mobile switching center (MSC) and sending a packet switched (PS) to CS Handover Request message to the MSC, where the PS to CS Handover Request message carries information required for the CS handover and a called number so that the MSC calls a called UE. The corresponding apparatuses and systems are also disclosed. The technical solution of the present invention can reduce the connection delay.
摘要翻译：本发明公开的用于语音呼叫回退到电路交换（CS）域的方法包括：从主叫用户设备（UE）接收业务请求消息，其中业务请求消息包括语音呼叫的被叫号码信息 CS域，指示演进的节点B（eNB）发起电路交换回退（CSFB）切换; 从eNB接收切换请求消息，其中切换请求消息包括CS切换所需的信息，选择移动交换中心（MSC）并向MSC切换请求消息发送分组交换（PS）到MSC，其中PS到 CS切换请求消息携带CS切换所需的信息和被叫号码，使得MSC呼叫被叫UE。还公开了相应的装置和系统。本发明的技术方案可以减少连接延迟。

50. 发明申请

US20120083474A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 有权
标题翻译：作为TRPA1的调节剂的杂环化合物
公开(公告)号：US20120083474A1
公开(公告)日：2012-04-05
申请号：US13375833
申请日：2010-06-04
申请人： Didier Jean-Claude Berthelot , Henricus Jacobus Maria Gijsen , Mirko Zaja , Jason Rech , Alec Lebsack , Wei Xiao , Bryan Branstetter , Guy J. Breitenbucher
发明人： Didier Jean-Claude Berthelot , Henricus Jacobus Maria Gijsen , Mirko Zaja , Jason Rech , Alec Lebsack , Wei Xiao , Bryan Branstetter , Guy J. Breitenbucher
IPC分类号： A61K31/635 , C07D403/12 , C07D401/14 , C07D409/14 , C07D413/14 , A61K31/506 , A61K31/513 , A61K31/5377 , A61K31/551 , C12N5/071 , A61P29/00 , A61P27/16 , A61P1/00 , A61P13/02 , A61P11/00 , A61P19/02 , A61P11/14 , A61P11/06 , C07D403/14
CPC分类号： C07D403/14 , C07D207/48 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/12 , C07D409/14
摘要： Certain heterocyclic amide compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPA1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease.
摘要翻译：描述了某些杂环酰胺化合物。所述化合物可用于治疗由TRPA1活性介导的疾病状态，病症和状况的药物组合物和方法，例如疼痛，关节炎，瘙痒，咳嗽，哮喘或炎症性肠病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式